Literature DB >> 21515054

Synthesis and evaluation of heteroarylalanine diacids as potent and selective neutral endopeptidase inhibitors.

Melanie S Glossop1, Richard J Bazin, Kevin N Dack, David N A Fox, Graeme A MacDonald, Mark Mills, Dafydd R Owen, Chris Phillips, Keith A Reeves, Tracy J Ringer, Ross S Strang, Christine A L Watson.   

Abstract

Heteroarylalanine derivatives 4 were designed as potential inhibitors of neutral endopeptidase (NEP EC 3.4.24.11). Selectivity over other zinc metalloproteinases was explored through occupation of the S2' subsite within NEP. Structural optimisation led to the identification of 5-phenyl oxazole 4f, a potent and selective NEP inhibitor. A crystal structure of the inhibitor bound complex is reported.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21515054     DOI: 10.1016/j.bmcl.2011.03.109

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

1.  Structure-Guided Design of Substituted Biphenyl Butanoic Acid Derivatives as Neprilysin Inhibitors.

Authors:  Toshio Kawanami; Rajeshri G Karki; Emma Cody; Qian Liu; Guiqing Liang; Gary M Ksander; Dean F Rigel; Nikolaus Schiering; Yongjin Gong; Gary M Coppola; Yuki Iwaki; Robert Sun; Alan Neubert; Li Fan; Sara Ingles; Allan D'Arcy; Frederic Villard; Paul Ramage; Arco Y Jeng; Jennifer Leung-Chu; Jing Liu; Michael Beil; Fumin Fu; Wei Chen; Frederic Cumin; Christian Wiesmann; Muneto Mogi
Journal:  ACS Med Chem Lett       Date:  2020-01-27       Impact factor: 4.345

2.  Structures of soluble rabbit neprilysin complexed with phosphoramidon or thiorphan.

Authors:  Shaunivan L Labiuk; Jurgen Sygusch; Pawel Grochulski
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2019-05-10       Impact factor: 1.056

3.  Structure of neprilysin in complex with the active metabolite of sacubitril.

Authors:  Nikolaus Schiering; Allan D'Arcy; Frederic Villard; Paul Ramage; Claude Logel; Frederic Cumin; Gary M Ksander; Christian Wiesmann; Rajeshri G Karki; Muneto Mogi
Journal:  Sci Rep       Date:  2016-06-15       Impact factor: 4.379

Review 4.  Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure.

Authors:  Lauren B Arendse; A H Jan Danser; Marko Poglitsch; Rhian M Touyz; John C Burnett; Catherine Llorens-Cortes; Mario R Ehlers; Edward D Sturrock
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

5.  Engineering neprilysin activity and specificity to create a novel therapeutic for Alzheimer's disease.

Authors:  Carl I Webster; Matthew Burrell; Lise-Lotte Olsson; Susan B Fowler; Sarah Digby; Alan Sandercock; Arjan Snijder; Jan Tebbe; Ulrich Haupts; Joanna Grudzinska; Lutz Jermutus; Christin Andersson
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.